Open AccessEfficacy of Generic Atorvastatin in a Real-World Setting
Author(s) -
Panisa Manasirisuk,
Nanthaphan Chainirun,
Somsak Tiamkao,
Sunee Lertsinudom,
Kutcharin Phunikhom,
Bundit Sawunyavisuth,
Kittisak Sawanyawisuth
Publication year - 2021
Publication title -
clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.685
H-Index - 27
ISSN - 1179-1438
DOI - 10.2147/cpaa.s285750
Subject(s) - atorvastatin , medicine , statin , retrospective cohort study , cohort , ldl cholesterol , cholesterol
The ability of statins to reduce LDL-c plays an important role in both primary and secondary prevention of atherosclerotic cardiovascular diseases. Such treatment can often be costly, but using generic atorvastatin may reduce cost by up to US$2635. In addition, a previous 8-week study found that it exhibited comparable efficacy to the brand-name medication. This study aimed to evaluate the efficacy of generic atorvastatin over a longer period of six months in a real-world setting.